BICLUSTER_ID : UPREG-92
PATHOGENS /3/ : pseudomonas aeruginosa,streptococcus pneumoniae,yersinia enterocolitica
TARGETS /11/ : CCL20, PDE4B, LDLR, JUN, BMP2, IL6, PTGS2, F3, PIM1, CD55, PLAUR
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPKLF6, LDLR, JUN, PDE4B, GADD45G, ETS2, SOCS3, PMAIP1, IL6, SOCS1, ID2, PLAUR, IER3
NETPATH IL 4 PATHWAY UPJUN, IBRDC3, KLF4, BCL2L11, CH25H, BMP2, TOX, SOCS3, IL6, F3, SOCS1
NETPATH IL 1 PATHWAY UPRHOB, CCL20, JUN, CXCL1, NFKBIE, IL6, PTGS2, ZFP36, CXCL2
NETPATH TNF ALPHA PATHWAY DOWNKLF6, CCL20, JUN, CXCL1, PLK2, KLF10, TIPARP, MAFF, IL6, PTGS2, TNFAIP3, ZFP36, CXCL2, IER3
NETPATH IL 4 PATHWAY DOWNIL6, CCL20, PTGS2, CDKN1A, CXCL2, DDIT4
NCI REG GR PATHWAYIL6, CDKN1A, JUN
NCI ATF2 PATHWAYSOCS3, ATF3, IL6, DUSP10, JUN, DUSP1
NETPATH IL 5 PATHWAY UPATF4, PDE4B, NFKBIE, CD55, MAPK6, IER3, GADD45A
NETPATH EGFR1 PATHWAY UPEMP1, PHLDA1, CDKN1A, EREG, PLK2, TNFAIP3, PTGS2, DUSP1, PLAUR, IER3
NETPATH IL 9 PATHWAY UPSOCS3, JUNB, CITED2, PIM1
NETPATH IL 7 PATHWAY UPCXCL1, JUN, CXCL2
NCI P53DOWNSTREAMPATHWAYPMAIP1, GDF15, ATF3, BBC3, CDKN1A, JUN, DUSP1
GERY CEBP TARGETSCLU, CXCL1, EREG, KLF4, GADD45G, ATF3, ID2, DUSP1, PLAUR
NETPATH KIT RECEPTOR PATHWAY UPGDF15, IL6, SOCS1, IER3
NETPATH IL 6 PATHWAY UPCLU, JUN, CXCL1, MAP3K8, SOCS3, MAFF, ZFP36, SOCS1, ID2
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MAHAJAN RESPONSE TO IL1A UP
BIOCARTA IL6 PATHWAY
LINDGREN BLADDER CANCER CLUSTER 2B
CHUANG OXIDATIVE STRESS RESPONSE UP
PEREZ TP53 AND TP63 TARGETS
SHEPARD CRUSH AND BURN MUTANT UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
NCI ERBB NETWORK PATHWAY
CHEN LVAD SUPPORT OF FAILING HEART UP
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
MCBRYAN PUBERTAL BREAST 4 5WK UP
SAKAI CHRONIC HEPATITIS VS LIVER CANCER DN
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
ODONNELL TFRC TARGETS UP
ELVIDGE HYPOXIA UP
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
VALK AML CLUSTER 1
AMIT EGF RESPONSE 40 HELA
MISHRA CARCINOMA ASSOCIATED FIBROBLAST UP
TOMIDA METASTASIS UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
NCI IL6 7PATHWAY
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
MARTORIATI MDM4 TARGETS FETAL LIVER UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
HINATA NFKB TARGETS KERATINOCYTE UP
GENTILE UV HIGH DOSE UP
DORN ADENOVIRUS INFECTION 48HR DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
AMIT SERUM RESPONSE 60 MCF10A
DUTTA APOPTOSIS VIA NFKB
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
TSAI RESPONSE TO IONIZING RADIATION
KRISHNAN FURIN TARGETS UP
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
DAZARD UV RESPONSE CLUSTER G4
BIOCARTA CD40 PATHWAY
HEIDENBLAD AMPLIFIED IN SOFT TISSUE CANCER
NCI NFAT TFPATHWAY
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
ONDER CDH1 TARGETS 3 DN
ZHOU INFLAMMATORY RESPONSE LIVE UP
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
VART KSHV INFECTION ANGIOGENIC MARKERS DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
DAZARD RESPONSE TO UV NHEK UP
MCLACHLAN DENTAL CARIES UP
WINTER HYPOXIA METAGENE
GAJATE RESPONSE TO TRABECTEDIN UP
PODAR RESPONSE TO ADAPHOSTIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
KERLEY RESPONSE TO CISPLATIN UP
OSAWA TNF TARGETS
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
LAU APOPTOSIS CDKN2A UP
ZHOU INFLAMMATORY RESPONSE LPS UP
BOQUEST STEM CELL CULTURED VS FRESH DN
GESERICK TERT TARGETS DN
BROWNE HCMV INFECTION 2HR UP
DORN ADENOVIRUS INFECTION 24HR DN
SESTO RESPONSE TO UV C3
FALVELLA SMOKERS WITH LUNG CANCER
VERHAAK AML WITH NPM1 MUTATED UP
AMIT EGF RESPONSE 40 MCF10A
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
ST TUMOR NECROSIS FACTOR PATHWAY
BIOCARTA ATM PATHWAY
ZHOU INFLAMMATORY RESPONSE FIMA UP
BOYLAN MULTIPLE MYELOMA PCA3 UP
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
ABE VEGFA TARGETS 2HR
MURAKAMI UV RESPONSE 1HR DN
GENTILE UV LOW DOSE UP
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
CORUM SMAD3-SMAD4-CJUN-CFOS COMPLEX
AMIT DELAYED EARLY GENES
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN
KRIGE AMINO ACID DEPRIVATION
PEREZ TP63 TARGETS
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
NOJIMA SFRP2 TARGETS UP
MISSIAGLIA REGULATED BY METHYLATION UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI TCRCALCIUMPATHWAY
LEONARD HYPOXIA
DORN ADENOVIRUS INFECTION 32HR DN
CROONQUIST STROMAL STIMULATION UP
LEE LIVER CANCER MYC TGFA UP
BOYLAN MULTIPLE MYELOMA C DN
CHANDRAN METASTASIS DN
BIOCARTA CCR5 PATHWAY
SAGIV CD24 TARGETS DN
SIMBULAN UV RESPONSE NORMAL UP
KEGG MAPK SIGNALING PATHWAY
BIOCARTA CDMAC PATHWAY
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
DORN ADENOVIRUS INFECTION 12HR UP
MAHADEVAN RESPONSE TO MP470 DN
DORN ADENOVIRUS INFECTION 12HR DN
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
BROWNE HCMV INFECTION 30MIN UP
NCI LYSOPHOSPHOLIPID PATHWAY
HARRIS HYPOXIA
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
NCI BH3 ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI APOPTOTIC BCL 2 MEMBERS
SEIKE LUNG CANCER POOR SURVIVAL
AMIT EGF RESPONSE 20 HELA
KAN RESPONSE TO ARSENIC TRIOXIDE
ENK UV RESPONSE KERATINOCYTE UP
BASSO CD40 SIGNALING UP
MUELLER METHYLATED IN GLIOBLASTOMA
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
SOUCEK MYC TARGETS
ENK UV RESPONSE EPIDERMIS DN
BIOCARTA PPARA PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
ZERBINI RESPONSE TO SULINDAC UP
SCIAN INVERSED TARGETS OF TP53 AND TP73 DN
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
GENTILE UV LOW DOSE DN
NETPATH B CELL RECEPTOR PATHWAY UP
MAHADEVAN RESPONSE TO MP470 UP
IVANOVA HEMATOPOIESIS STEM CELL
RASHI RESPONSE TO IONIZING RADIATION 1
FERRARI RESPONSE TO FENRETINIDE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY UP
BILD HRAS ONCOGENIC SIGNATURE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
NETPATH IL 3 PATHWAY UPSOCS3, SOCS1
MENSE HYPOXIA UP
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
AMIT EGF RESPONSE 60 HELA
BERENJENO TRANSFORMED BY RHOA FOREVER DN
MARKS HDAC TARGETS DN
KANNAN TP53 TARGETS UP
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
NCI CD40 PATHWAY
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
HELLER SILENCED BY METHYLATION DN
BIERIE INFLAMMATORY RESPONSE TGFB1
SENESE HDAC1 AND HDAC2 TARGETS UP
WANG METHYLATED IN BREAST CANCER
ONDER CDH1 TARGETS 2 DN
SENESE HDAC1 TARGETS UP
SHI SPARC TARGETS DN
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
ODONNELL TARGETS OF MYC AND TFRC UP
KIM WT1 TARGETS UP
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
KOBAYASHI EGFR SIGNALING 6HR DN
BIOCARTA KERATINOCYTE PATHWAY
NCI AVB3 OPN PATHWAY
BIOCARTA TNFR2 PATHWAY
WANG HCP PROSTATE CANCER
BROWNE HCMV INFECTION 1HR UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
DASU IL6 SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
CHIBA RESPONSE TO TSA UP
HOFMANN MYELODYSPLASTIC SYNDROM RISK UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
GOUYER TATI TARGETS UP
NETPATH WNT PATHWAY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
ZUCCHI METASTASIS DN
SMID BREAST CANCER RELAPSE IN BONE DN
BIOCARTA ARENRF2 PATHWAY
SMID BREAST CANCER BASAL UP
PRAMOONJAGO SOX4 TARGETS UP
KIM WT1 TARGETS 8HR UP
CORUM ETS2-FOS-JUN COMPLEX
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
LU TUMOR ENDOTHELIAL MARKERS UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica wap bcpseudomonas aeruginosastreptococcus pneumoniae tigr4GeneSet Name
0.00010 0.11013 0.07061NETPATH_IL_2_PATHWAY_UP
0.00017 0.08967 0.00685NETPATH_IL_4_PATHWAY_UP
0.00001 0.00004 0.00001NETPATH_IL_1_PATHWAY_UP
0.00000 0.00764 0.00000NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.00024 0.00000 0.01938NETPATH_IL_4_PATHWAY_DOWN
0.01695 0.03680 0.01495NCI_REG_GR_PATHWAY
0.00040 0.00003 0.00028NCI_ATF2_PATHWAY
0.00001 0.00238 0.00002NETPATH_IL_5_PATHWAY_UP
0.00014 0.02903 0.00000NETPATH_EGFR1_PATHWAY_UP
0.00001 0.06627 0.05141NETPATH_IL_9_PATHWAY_UP
0.00052 0.00151 0.00009NETPATH_IL_7_PATHWAY_UP
0.01652 0.04260 0.00000NCI_P53DOWNSTREAMPATHWAY
0.00013 0.00843 0.00001GERY_CEBP_TARGETS
0.00004 0.05123 0.00001NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00000 0.01244 0.00000NETPATH_IL_6_PATHWAY_UP
0.00000 0.01558 0.00058GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00000 0.00000 0.00006MAHAJAN_RESPONSE_TO_IL1A_UP
0.17070 0.03352 0.01655BIOCARTA_IL6_PATHWAY
0.00193 0.09315 0.08490LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.05875 0.17995 0.00051CHUANG_OXIDATIVE_STRESS_RESPONSE_UP
0.04397 0.14834 0.07906PEREZ_TP53_AND_TP63_TARGETS
0.05907 0.04313 0.00000SHEPARD_CRUSH_AND_BURN_MUTANT_UP
0.01376 0.01543 0.18700MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.00403 0.14165 0.01776NCI_ERBB_NETWORK_PATHWAY
0.00011 0.11056 0.00000CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.07725 0.09360 0.00292TENEDINI_MEGAKARYOCYTE_MARKERS
0.00004 0.00005 0.00796LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.04260 0.13408 0.02036MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.14424 0.13870 0.11570SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN
0.00001 0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00387 0.15403LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.01065 0.02390 0.02026LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.05414 0.03876 0.02206ODONNELL_TFRC_TARGETS_UP
0.00006 0.10177 0.00000ELVIDGE_HYPOXIA_UP
0.06007 0.00802 0.08439IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.02918 0.01005 0.00046VALK_AML_CLUSTER_1
0.00018 0.00000 0.00000AMIT_EGF_RESPONSE_40_HELA
0.00162 0.01601 0.01028MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP
0.15132 0.07164 0.00109TOMIDA_METASTASIS_UP
0.01552 0.00150 0.00224YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00542 0.11752 0.04977MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.07031 0.00094 0.11902JEON_SMAD6_TARGETS_UP
0.00513 0.08410 0.00323MITSIADES_RESPONSE_TO_APLIDIN_UP
0.08946 0.09153 0.00381NCI_IL6_7PATHWAY
0.00000 0.00381 0.00077THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00012 0.13363 0.07760TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.05709 0.02052 0.02611LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.07895 0.10352 0.00087MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP
0.02964 0.10385 0.00024TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00000 0.00000 0.00741HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.02916 0.01593 0.00764GENTILE_UV_HIGH_DOSE_UP
0.01624 0.00817 0.00001DORN_ADENOVIRUS_INFECTION_48HR_DN
0.00372 0.13427 0.00726KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00000 0.00004 0.02561KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.04407 0.00321 0.03617DAZARD_UV_RESPONSE_CLUSTER_G3
0.00000 0.00092 0.00000AMIT_SERUM_RESPONSE_60_MCF10A
0.00003 0.00086 0.00090DUTTA_APOPTOSIS_VIA_NFKB
0.00313 0.00182 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.05125 0.03182 0.03596TSAI_RESPONSE_TO_IONIZING_RADIATION
0.13352 0.01934 0.08033KRISHNAN_FURIN_TARGETS_UP
0.00000 0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00850 0.01592 0.17933DER_IFN_GAMMA_RESPONSE_UP
0.00333 0.00111 0.00225DAZARD_UV_RESPONSE_CLUSTER_G4
0.09812 0.00168 0.06184BIOCARTA_CD40_PATHWAY
0.11415 0.18633 0.00991HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER
0.00259 0.13386 0.00004NCI_NFAT_TFPATHWAY
0.00000 0.01100 0.00000GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.01083 0.00003 0.00000ONDER_CDH1_TARGETS_3_DN
0.00000 0.00000 0.00172ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00000 0.00184 0.00000AMIT_EGF_RESPONSE_120_HELA
0.02104 0.01532 0.05739BIOCARTA_RANKL_PATHWAY
0.02648 0.00459 0.06462VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN
0.00012 0.00593 0.05863NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00323 0.00080 0.00000DAZARD_RESPONSE_TO_UV_NHEK_UP
0.00000 0.00000 0.18322MCLACHLAN_DENTAL_CARIES_UP
0.00004 0.10229 0.00002WINTER_HYPOXIA_METAGENE
0.00903 0.08239 0.00103GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.00000 0.13378 0.00000PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00007 0.04250 0.00114SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00000 0.07679 0.00001GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.00000 0.00185 0.01424FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00036 0.09452GAURNIER_PSMD4_TARGETS
0.09819 0.07565 0.00312KERLEY_RESPONSE_TO_CISPLATIN_UP
0.05837 0.00364 0.04111OSAWA_TNF_TARGETS
0.03490 0.01071 0.00028SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.00897 0.06664 0.00272LAU_APOPTOSIS_CDKN2A_UP
0.00000 0.00043 0.05005ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.14177 0.18974 0.04615BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN
0.00000 0.00178 0.00000GESERICK_TERT_TARGETS_DN
0.02213 0.00000 0.00000BROWNE_HCMV_INFECTION_2HR_UP
0.00323 0.03149 0.00000DORN_ADENOVIRUS_INFECTION_24HR_DN
0.00406 0.00703 0.00000SESTO_RESPONSE_TO_UV_C3
0.03002 0.11253 0.01335FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.00000 0.00267 0.01022VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00643 0.00321 0.00000AMIT_EGF_RESPONSE_40_MCF10A
0.00000 0.00051 0.03793GEISS_RESPONSE_TO_DSRNA_UP
0.00011 0.02559 0.00170GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.17372 0.00376 0.09063CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.02172 0.00000 0.10060ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.04533 0.06930 0.01950BIOCARTA_ATM_PATHWAY
0.00001 0.00000 0.02569ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.09804 0.07637 0.01305BOYLAN_MULTIPLE_MYELOMA_PCA3_UP
0.00188 0.06576 0.00000CHASSOT_SKIN_WOUND
0.00000 0.00000 0.00001TIAN_TNF_SIGNALING_VIA_NFKB
0.03825 0.09694 0.01936ABE_VEGFA_TARGETS_2HR
0.09395 0.02825 0.19116MURAKAMI_UV_RESPONSE_1HR_DN
0.00750 0.00359 0.00028GENTILE_UV_LOW_DOSE_UP
0.00193 0.00093 0.01752LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00102 0.00000NAGASHIMA_EGF_SIGNALING_UP
0.19423 0.17976 0.04867CORUM_SMAD3-SMAD4-CJUN-CFOS_COMPLEX
0.00156 0.04481 0.00000AMIT_DELAYED_EARLY_GENES
0.09537 0.05493 0.00046HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.00024 0.00099 0.00068KRIGE_AMINO_ACID_DEPRIVATION
0.01876 0.08962 0.17915PEREZ_TP63_TARGETS
0.00000 0.00367 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.00001 0.00000 0.00038HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.04368 0.03016 0.00381RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00224 0.06631 0.00000NOJIMA_SFRP2_TARGETS_UP
0.00107 0.00002 0.05746MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00133 0.02594 0.00812SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00000 0.00003 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.05118 0.12883 0.00024NCI_TCRCALCIUMPATHWAY
0.00652 0.09020 0.00001LEONARD_HYPOXIA
0.01879 0.00267 0.00000DORN_ADENOVIRUS_INFECTION_32HR_DN
0.00829 0.01456 0.00000CROONQUIST_STROMAL_STIMULATION_UP
0.18770 0.17247 0.14214LEE_LIVER_CANCER_MYC_TGFA_UP
0.02924 0.15801 0.00574BOYLAN_MULTIPLE_MYELOMA_C_DN
0.04629 0.00166 0.00003CHANDRAN_METASTASIS_DN
0.00898 0.15535 0.17164BIOCARTA_CCR5_PATHWAY
0.02459 0.00003 0.00002SAGIV_CD24_TARGETS_DN
0.00821 0.00361 0.00048SIMBULAN_UV_RESPONSE_NORMAL_UP
0.04922 0.06687 0.03665KEGG_MAPK_SIGNALING_PATHWAY
0.04613 0.00389 0.00114BIOCARTA_CDMAC_PATHWAY
0.01934 0.04274 0.00068GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.01175 0.19042 0.00004DORN_ADENOVIRUS_INFECTION_12HR_UP
0.00006 0.00187 0.00000MAHADEVAN_RESPONSE_TO_MP470_DN
0.09384 0.06010 0.00432DORN_ADENOVIRUS_INFECTION_12HR_DN
0.00124 0.06176 0.07890CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.13301 0.02842 0.00102BROWNE_HCMV_INFECTION_30MIN_UP
0.10752 0.09661 0.01481NCI_LYSOPHOSPHOLIPID_PATHWAY
0.00004 0.00391 0.00000HARRIS_HYPOXIA
0.17539 0.14826 0.10905TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.00057 0.08417 0.00577KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.08477 0.04046 0.05782NCI_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS
0.00572 0.09189 0.05865SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.06004 0.00091 0.00019AMIT_EGF_RESPONSE_20_HELA
0.00286 0.00906 0.00024KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.01772 0.00000 0.00002ENK_UV_RESPONSE_KERATINOCYTE_UP
0.00000 0.00006 0.01887BASSO_CD40_SIGNALING_UP
0.09968 0.06034 0.11195MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.02315 0.15889 0.14147BIOCARTA_NTHI_PATHWAY
0.00034 0.05837 0.00000TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00000 0.00113 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.00001 0.00251 0.02991SOUCEK_MYC_TARGETS
0.00120 0.09100 0.00050ENK_UV_RESPONSE_EPIDERMIS_DN
0.00401 0.09219 0.01946BIOCARTA_PPARA_PATHWAY
0.00000 0.00023 0.04093TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.16203 0.08983 0.00038ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00417 0.17466 0.12713SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN
0.01616 0.06142 0.16764WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.01642 0.07194 0.06538FRIDMAN_SENESCENCE_UP
0.08739 0.04253 0.00343WU_HBX_TARGETS_2_DN
0.00814 0.00316 0.00037GENTILE_UV_LOW_DOSE_DN
0.00361 0.10186 0.14179NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00006 0.00009 0.05724MAHADEVAN_RESPONSE_TO_MP470_UP
0.00396 0.06636 0.01602IVANOVA_HEMATOPOIESIS_STEM_CELL
0.07395 0.00353 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_1
0.00007 0.00003 0.00024FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.18766 0.03417 0.15451GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP
0.00000 0.00110 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.00007 0.00126 0.13850LIANG_SILENCED_BY_METHYLATION_2
0.06147 0.00006 0.00000DAUER_STAT3_TARGETS_UP
0.00000 0.01596 0.00810NETPATH_IL_3_PATHWAY_UP
0.00167 0.10399 0.00000MENSE_HYPOXIA_UP
0.00197 0.02053 0.00000ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00000 0.17983 0.00000AMIT_EGF_RESPONSE_60_HELA
0.00000 0.00379 0.00046BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.01162 0.07473 0.15432MARKS_HDAC_TARGETS_DN
0.01126 0.02791 0.00146KANNAN_TP53_TARGETS_UP
0.00001 0.00776 0.00003CHEN_HOXA5_TARGETS_9HR_UP
0.00772 0.01158 0.00000DAZARD_UV_RESPONSE_CLUSTER_G2
0.03530 0.00075 0.11127NCI_CD40_PATHWAY
0.00000 0.00028 0.00000AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00008 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00014 0.00121 0.00250CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00000 0.00000 0.00001ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00072 0.02836 0.06732HELLER_SILENCED_BY_METHYLATION_DN
0.00509 0.00508 0.00416BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00001 0.03137 0.05989SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00001 0.17963 0.00000WANG_METHYLATED_IN_BREAST_CANCER
0.00111 0.00503 0.10479ONDER_CDH1_TARGETS_2_DN
0.00001 0.16126 0.08992SENESE_HDAC1_TARGETS_UP
0.08510 0.04245 0.06766SHI_SPARC_TARGETS_DN
0.02958 0.00399 0.00001INGA_TP53_TARGETS
0.00000 0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.03834 0.02044 0.02726ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.00000 0.00318 0.00001KIM_WT1_TARGETS_UP
0.00000 0.00002 0.00000UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.00157 0.00180 0.09671XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.14658 0.00269 0.00001KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.03525 0.03442 0.04968BIOCARTA_KERATINOCYTE_PATHWAY
0.01130 0.00940 0.10200NCI_AVB3_OPN_PATHWAY
0.14415 0.00125 0.13073BIOCARTA_TNFR2_PATHWAY
0.00844 0.06338 0.06003WANG_HCP_PROSTATE_CANCER
0.07820 0.00403 0.00980BROWNE_HCMV_INFECTION_1HR_UP
0.00000 0.15886 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00001 0.00000 0.00007DASU_IL6_SIGNALING_UP
0.00045 0.03582 0.00000ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00001 0.00069 0.00000AMIT_EGF_RESPONSE_120_MCF10A
0.00558 0.16041 0.03030CHIBA_RESPONSE_TO_TSA_UP
0.01521 0.13348 0.00964HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP
0.00000 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.00294 0.06637 0.15861GOUYER_TATI_TARGETS_UP
0.01134 0.13395 0.00000NETPATH_WNT_PATHWAY_UP
0.00000 0.00003 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00010 0.00002 0.00000ZUCCHI_METASTASIS_DN
0.13932 0.19699 0.16365SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.06920 0.06917 0.00046BIOCARTA_ARENRF2_PATHWAY
0.00269 0.18445 0.19757SMID_BREAST_CANCER_BASAL_UP
0.00024 0.00151 0.00000PRAMOONJAGO_SOX4_TARGETS_UP
0.00153 0.06159 0.00887KIM_WT1_TARGETS_8HR_UP
0.09984 0.11161 0.05298CORUM_ETS2-FOS-JUN_COMPLEX
0.00000 0.04258 0.00000PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.04480 0.09212 0.00069YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.09440 0.03006 0.16737LU_TUMOR_ENDOTHELIAL_MARKERS_UP